Infratrac believes that personalized medicine can be developed using point-of-care drug printing

The National Institute of Standards and Technology (NIST) awarded Infratrac Inc., a woman-owned small business, a $400,000 Cooperative Agreement under CFDA 11.620 - Science, Technology, Business and/or Education Outreach. The purpose of the award is for Infratrac to build upon its prior Phase I research demonstrating an integrated system using non-destructive technology with the potential to enhance trust and safety for 3D printed drugs. Under the Phase II project, Infratrac will focus on creating enforceable quality parameters to accommodate personalized drug dosing, expanding the scope to include more drugs, doses, and failure types. The goal is to integrate detection and prediction capabilities into a commercially-viable process control tool for hospital pharmacies and other point-of-care facilities to prevent inadvertent administration of 3D printed doses with the wrong medication amount. Infratrac will leverage subcontractors from the University of Maryland School of Pharmacy and FabRx, a 3D pharmaceutical printing company, to execute the project.

Activities

In phase II, infratrac will demonstrate how IT will detect and control for safety and quality issues in point-of-care 3D drug printing. They plan to expand the scope of research and development to include additional drugs and doses, include more failure types, and perform detection and predication capability into a commercially-viable tool for process control.

Expected outcomes

Infratrac?s technology aims to provide hospital pharmacies and other point-of-care facilities with a mechanism to protect patients by preventing the inadvertent administration of 3D printed doses containing either too much or too little of the prescribed medication.

Intended beneficiaries

Hospitals, pharmacies, the general public, especially children and seniors, those with allergies, and other patients requiring non-standard, complex, easily swallowed, or in-between dosing of medications.

Subrecipient activities

Recipient will use the following subcontractors:1. Applied pharmaceutics lab at university of MD school of PHARMACY2. Fabrx - a company that prints 3D printed dosage forms